The following information are provided by my stock broker and originated from Reuters Investment Profile
 
=====
TWD Financial Summary
BRIEF: For the fiscal year ended 31 December 2014, Tweed Marijuana Inc revenues totaled C
$1.1M. Net loss totaled to C$8.9M. Results are not comparable due to year end change
 
BED Financial Summary
BRIEF: For the nine months ended 31 October 2014, Bedrocan Cannabis Corp revenues increased
from C$0K to C$1.1M. Net loss increased from C$125K to C$4.1M. Revenues reflect an increase in
demand for the Company's products and services due to favorable market conditions. Basic Earnings
per Share excluding Extraordinary Items increased from -C$0.15 to -C$0.08.
 
MT Financial Summary
BRIEF: For the six months ended 31 December 2014, Mettrum Health Corp revenues totaled C
$1.5M. Net loss totaled to C$4M. Results are not comparable due to year end change.
 
OGI Financial Summary
BRIEF: For the three months ended 30 November 2014, OrganiGram Holdings Inc revenues totaled
C$13K. Net loss totaled to C$819K. Results are not comparable due to year end change.
 
TPI Financial Summary
BRIEF: For the six months ended 30 September 2014, T-Bird Pharma Inc revenues totaled C$23K.Net loss totaled to C$1.7M. Results are not comparable due to year end change
 
======

All the above 5 LPs have been traded for more than 6 months since IPO

IMHO MT is in the 1st position. BED is 2nd. TWD is 3rd

OGI and TPI are both in trouble. OGI needs some good sales number otherwise, it would be taken over soon(just like what happened to TPI, two founders are bought out today)